Summary: REMSleep Holdings has announced a delay in the market release of its Deltawave nasal pillows CPAP mask, now anticipated to launch in January 2025. The company attributes the delay to challenges with regulatory compliance and supply chain coordination, particularly for critical materials like medical-grade silicone. Despite setbacks, REMSleep notes it remains focused on ensuring FDA compliance and optimizing its product development process, with plans to secure distribution partners and upgrade its e-commerce platform.
Key Takeaways:
- Launch Delayed for Regulatory Compliance: The release of REMSleep’s FDA-cleared Deltawave CPAP mask is now delayed to January 2025 to align with FDA regulations and supplier timelines.
- Supply Chain Issues Cited: The delay also involves challenges in securing specialized materials, such as medical-grade silicone, which must match production schedules.
- Ongoing Preparations: The company is working on finalizing distributor agreements, upgrading its website, and advancing new product development to streamline future releases.
REMSleep Holdings announced a delay in the launch of its Deltawave nasal pillows CPAP mask, now projected for release in January 2025, citing regulatory and supply chain challenges.
The company emphasized that the delay is necessary to ensure full compliance with US Food and Drug Administration regulations and align with supplier schedules for critical materials like medical-grade silicone.
“For those who have been questioning the delays and disagree with the momentum and the timelines we have been navigating, we believe that we have been responsible and prudent based on the cadence of approvals presented,” reads a release from the company. “As much as we would have liked to pull the trigger for mass production earlier, we had to hold on many different occasions to be assured we were investing our money wisely as timelines and regulations continued to change.”
The company provided updates on major workstreams to date:
- Secured two major distributors who are waiting for completed products to be evaluated.
- Currently upgrading the website to better represent current and new product lines as well as integrating up-to-date e-commerce capabilities.
- New product development continues with molds in the pipeline in anticipation of a smooth 510(k) for new product development based on lessons learned from the past.
REMSleep Holdings was granted 510(K) clearance for its DeltaWave nasal pillow CPAP interface mask in July. The Deltawave nasal pillow mask is designed to enhance comfort and airflow, addressing a common issue where uncomfortable masks lead patients to discontinue therapy. Utilizing fluid dynamics, the mask aims to maintain natural respiratory rates by ensuring consistent airflow without mechanical disruptions.
“We greatly appreciate those who have ‘hung in there’ with us through these tumultuous years. One thing should be clear to our investors, we are all determined to get the Deltawave as well as other new products into the marketplace,” the company’s release reads.
ID 325549974 © Andrii Yalanskyi | Dreamstime.com
Leave a Reply